Skip to main content Back to Top
Advertisement

Droperidol – A resurrected option

Broadcast Date: December 4, 2020

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Droperidol has come back to the market after several years of being unavailable. Today's episode will discuss its potential place in practice, along with practical considerations, such as dosing and monitoring.

SPEAKERS

David ZimmermanDavid Zimmerman, Pharm.D.,BCPS, BCCCP is an Associate Professor of Pharmacy/EM Clinical Pharmacist in Duquesne University/UPMC-Mercy Hospital located in Pittsburgh, PA. He is also the Vice is also the Chair of the Emergency Care Advisory Group of the Section of Clinical Specialists and Scientists of ASHP.

Mark SkildumMark Skildum received his Bachelor of Arts in Biology from Saint Olaf College and received his PharmD with Leadership Emphasis from the University of Minnesota-College of Pharmacy. He completed a PGY-1 Residency and a PGY2 Health System Pharmacy Administration Residency at United Hospital in Saint Paul, MN. He is a graduate of the ASHP Foundation Pharmacy Leadership Academy. Mark currently serves as a clinical pharmacy manager at United Hospital – part of Allina Health in Saint Paul, Minnesota with responsibilities for the cardiology, neurology, critical care and emergency medicine teams. He lives in Roseville, MN with his wife (Lauren) and two children (Greta, 6 and Lars, 4). Mark has served on ASHP’s Section Advisory Groups for Advancing Practice with Pharmacy Technicians and currently serves on the Section Advisory Group for Emergency Medicine. He has served on multiple committees and roles in the Minnesota Society of Health System Pharmacists including Resident Liaison to the Board of Directors, Chair of the New Practitioner Committee and as a co-chair of the Education and Practice committee.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.